Through Malaria No More's Power of One campaign, treatment sponsor Novartis has raised enough money to procure 3 million antimalaria treatments for children in Zambia, the company announced on Wednesday.
“Power of One is a natural extension of our company’s commitment to the fight against malaria, and I am very proud of the contributions Novartis associates have made to help children in Zambia,” Joseph Jimenez, CEO of Novartis, said. “Over the past decade, we have delivered 700 million antimalarial treatments without profit in malaria-endemic countries, but more work is needed."
Although malaria is preventable and treatable, the World Health Organization says on average, a child dies every minute from malaria.
"We need to continue to step up efforts, not only by increasing access to antimalarials, but also by researching next-generation treatments to move closer to our vision of a malaria-free world," Jimenez said.
For every treatment funded by the public through the Power of One campaign, Novartis has pledged to match the donations through 2015.
“After only a year, thanks to the generosity of the global public and Novartis associates, we have been able to meet our goal of raising 3 million treatments for children in Zambia,” Martin Edlund, CEO of Malaria No More, said. “This is a great achievement, but we need to continue the fight and help ensure no child dies from malaria due to lack of a $1 treatment.”